A phase II Trial of Weekly Paclitaxel, 5-Fluorouracil, and Leucovorin as First-Line Treatment for Metastatic Breast Cancer

被引：0
|
作者：
David M. Loesch
Lina Asmar
Vikki A. Canfield
Gregory A. Parker
Harry E. Hynes
Peter G. Ellis
William A. Ferri
Nicholas J. Robert
机构：
[1] Oncology and Hematology Associates,
[2] Inc.,undefined
[3] US Oncology,undefined
[4] Cancer Care Associates,undefined
[5] Cancer Care Associates,undefined
[6] Cancer Center of Kansas,undefined
[7] PA,undefined
[8] Oncology Hematology Associates,undefined
[9] Oncology Hematology Associates,undefined
[10] Fairfax-Prince William Hematology-Oncology PC,undefined
来源：
Breast Cancer Research and Treatment | 2003年 / 77卷
关键词：
fluorouracil; leucovorin; metastatic breast cancer; paclitaxel; therapy; weekly;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Purpose. This phase II multicenter trial evaluated the efficacy and toxicity of weekly paclitaxel, 5-fluorouracil, and leucovorin administered as first-line therapy for metastatic breast cancer.
引用
收藏
页码：115 / 123
页数：8
相关论文
共 50 条
  • [21] First-line panitumumab plus irinotecan/5-fluorouracil/leucovorin treatment in patients with metastatic colorectal cancer
    Claus-Henning Köhne
    Ralf Hofheinz
    Laurent Mineur
    Henry Letocha
    Richard Greil
    Josef Thaler
    Eva Fernebro
    Erick Gamelin
    Lucy DeCosta
    Meinolf Karthaus
    Journal of Cancer Research and Clinical Oncology, 2012, 138 : 65 - 72
  • [22] Bevacizumab in combination with irinotecan, 5-fluorouracil and leucovorin given as first-line treatment of metastatic colorectal cancer
    Rocha, Jose Aurillo
    ANTI-CANCER DRUGS, 2011, 22 : S9 - S13
  • [23] First-line panitumumab plus irinotecan/5-fluorouracil/leucovorin treatment in patients with metastatic colorectal cancer
    Koehne, Claus-Henning
    Hofheinz, Ralf
    Mineur, Laurent
    Letocha, Henry
    Greil, Richard
    Thaler, Josef
    Fernebro, Eva
    Gamelin, Erick
    DeCosta, Lucy
    Karthaus, Meinolf
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2012, 138 (01) : 65 - 72
  • [24] Phase II trial of weekly paclitaxel, cisplatin plus infusional high dose 5-fluorouracil and leucovorin for metastatic urothelial carcinoma
    Lin, Chia-Chi
    Hsu, Chih-Hung
    Huang, Chao-Yuan
    Cheng, Ann-Lii
    Vogelzang, Nicholas J.
    Pu, Yeong-Shiau
    JOURNAL OF UROLOGY, 2007, 177 (01): : 84 - 89
  • [25] A phase II study of irinotecan, oxaliplatin, 5-fluorouracil, leucovorin (FOLFOXIRI) as a first-line chemotherapy in metastatic gastric cancer.
    Lee, J.
    Kang, W.
    Lee, S.
    Kwon, J.
    Kim, H.
    Lee, H.
    Lim, H.
    Park, J.
    Park, Y.
    Park, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 197S - 197S
  • [26] Weekly paclitaxel as first-line chemotherapy for elderly patients with metastatic breast cancer. A multicentre phase II trial
    ten Tije, AJ
    Smorenburg, CH
    Seynaeve, C
    Sparrebooma, A
    Schothorst, KLC
    Kerkhofs, LGM
    van Reisen, LGPM
    Stoter, G
    Bontenbal, M
    Verweij, J
    EUROPEAN JOURNAL OF CANCER, 2004, 40 (03) : 352 - 357
  • [27] Phase II study of irinotecan, 5-fluorouracil and leucovorin as first-line therapy for advanced colorectal cancer
    Ji, SH
    Park, YS
    Lee, J
    Lim, DH
    Park, BB
    Park, KW
    Kang, JH
    Lee, SH
    Park, JO
    Kim, K
    Kim, WS
    Jung, CW
    Im, YH
    Kang, WK
    Park, K
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2005, 35 (04) : 214 - 217
  • [28] Phase II Study of Biweekly Paclitaxel Plus Infusional 5-Fluorouracil and Leucovorin as First-Line Chemotherapy in Patients With Advanced Gastric Cancer
    Wang, Fenghua
    Wang, Zhiqiang
    Zhou, Ningning
    An, Xin
    Xu, Ruihua
    He, Youjian
    Li, Yuhong
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2011, 34 (04): : 401 - 405
  • [29] Phase II study of weekly vinorelbine and 24-h infusion of high-dose 5-fluorouracil plus leucovorin as first-line treatment of advanced breast cancer
    Yeh, KH
    Lu, YS
    Hsu, CH
    Lin, JF
    Chao, HJ
    Huang, TC
    Chung, CY
    Chang, CS
    Yang, CH
    Cheng, AL
    BRITISH JOURNAL OF CANCER, 2005, 92 (06) : 1013 - 1018
  • [30] Phase II study of weekly vinorelbine and 24-h infusion of high-dose 5-fluorouracil plus leucovorin as first-line treatment of advanced breast cancer
    K H Yeh
    Y S Lu
    C H Hsu
    J F Lin
    H J Chao
    T C Huang
    C Y Chung
    C S Chang
    C H Yang
    A L Cheng
    British Journal of Cancer, 2005, 92 : 1013 - 1018
12345